These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30098167)

  • 21. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.
    Kitzmann AS; Pulido JS; Diehl NN; Hodge DO; Burke JP
    Ophthalmology; 2008 Jan; 115(1):169-73. PubMed ID: 18166410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Correlation of Central Serous Chorioretinopathy and Subsequent Cardiovascular Diseases of Different Types: A Population-Based Cohort Study.
    Hsu HJ; Lee CY; Chao SC; Nien CW; Tzeng SH; Huang JY; Ko TC; Yang SF; Lin HY
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31847232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central Serous Chorioretinopathy in a 14-year-old atopic boy: a case report.
    Ranno S; Fontanel L; Ruggiero E; Nucci P; Radice P; Donati S
    Ital J Pediatr; 2023 Jan; 49(1):1. PubMed ID: 36597009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk for central serous chorioretinopathy in nephrotic syndrome patients: A population-based cohort study.
    Lee LC; Wu TJ; Huang KH; Chen YH; Chen JT; Chung CH; Chien WC; Chen CL
    J Chin Med Assoc; 2021 Nov; 84(11):1060-1069. PubMed ID: 34320516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature.
    Nakatsuka AS; Khanamiri HN; Lam QN; El-Annan J
    Hawaii J Med Public Health; 2019 May; 78(5):151-154. PubMed ID: 31049263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RISK OF RETINAL VEIN OCCLUSION WITH CENTRAL SEROUS CHORIORETINOPATHY.
    Chang YS; Chang C; Weng SF; Wang JJ; Jan RL
    Retina; 2016 Apr; 36(4):798-804. PubMed ID: 26441266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.
    Haimovici R; Gragoudas ES; Duker JS; Sjaarda RN; Eliott D
    Ophthalmology; 1997 Oct; 104(10):1653-60. PubMed ID: 9331207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RISK OF RHEGMATOGENOUS RETINAL DETACHMENT WITH CENTRAL SEROUS CHORIORETINOPATHY.
    Chang YS; Chang C; Weng SF; Wang JJ; Jan RL
    Retina; 2016 Aug; 36(8):1446-53. PubMed ID: 26716956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease.
    Ricketti PA; Unkle DW; Cleri DJ; Prenner JL; Coluccielo M; Ricketti AJ
    Allergy Asthma Proc; 2015; 36(2):123-9. PubMed ID: 25715240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHOROIDAL THICKNESS OF CENTRAL SEROUS CHORIORETINOPATHY SECONDARY TO CORTICOSTEROID USE.
    Honda S; Miki A; Kusuhara S; Imai H; Nakamura M
    Retina; 2017 Aug; 37(8):1562-1567. PubMed ID: 27787451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central serous chorioretinopathy associated with topical corticosteroids in a patient with psoriasis.
    Ezra N; Taban M; Behroozan D
    J Drugs Dermatol; 2011 Aug; 10(8):918-21. PubMed ID: 21818516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study.
    French DD; Margo CE
    Retina; 2010 Feb; 30(2):271-4. PubMed ID: 20010456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of inhaled and oral corticosteroids and the long-term risk of cataract.
    Wang JJ; Rochtchina E; Tan AG; Cumming RG; Leeder SR; Mitchell P
    Ophthalmology; 2009 Apr; 116(4):652-7. PubMed ID: 19243828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study.
    Tsai DC; Huang CC; Chen SJ; Chou P; Chung CM; Chan WL; Huang PH; Chen TJ; Lin SJ; Chen JW; Leu HB
    Br J Ophthalmol; 2012 Dec; 96(12):1484-8. PubMed ID: 22976583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis.
    Jang YH; Choi EY; Lee H; Woo J; Park S; Noh Y; Jeon JY; Yoo EY; Shin JY; Lee YW
    JAMA Netw Open; 2024 Jul; 7(7):e2423563. PubMed ID: 39028668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Physical Activity Level With Risk of Dementia in a Nationwide Cohort in Korea.
    Yoon M; Yang PS; Jin MN; Yu HT; Kim TH; Jang E; Uhm JS; Pak HN; Lee MH; Joung B
    JAMA Netw Open; 2021 Dec; 4(12):e2138526. PubMed ID: 34913979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study.
    Breukink MB; Mohabati D; van Dijk EH; den Hollander AI; de Jong EK; Dijkman G; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Sep; 94(6):565-72. PubMed ID: 27149889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choroidal thickness evaluation of healthy eyes, central serous chorioretinopathy, and fellow eyes using spectral domain optical coherence tomography in Indian population.
    Arora S; Pyare R; Sridharan P; Arora T; Thakar M; Ghosh B
    Indian J Ophthalmol; 2016 Oct; 64(10):747-751. PubMed ID: 27905337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central serous chorioretinopathy, corticosteroids, and uveitis.
    Khairallah M; Kahloun R; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2012 Apr; 20(2):76-85. PubMed ID: 22409559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of retinopathy in women with pregnancy-induced hypertension: a nationwide population-based cohort study of 9-year follow-up after delivery.
    Lee H; Yang SW; Kim Y; Shin H; Seo YS; Oh MJ; Choi S; Cho GJ; Hwang HS
    Am J Obstet Gynecol MFM; 2023 Jul; 5(7):100985. PubMed ID: 37119970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.